Prot #INCB 24360-203: A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCB024360 (Epacadostat) in Combination With MEDI4736 (Durvalumab) in Subjects With Selected Advanced Solid Tumors

  • Matsangou, Maria (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date3/1/173/1/20

Funding

  • inVentiv Health Clinical (Prot #INCB 24360-203)
  • Incyte Corporation (Prot #INCB 24360-203)